SCHEMBL17758993

SCHEMBL17758993

Cc1ccc2c(oc3cc4c(cc32)-c2cccnc2C4(C)C)c1-c1ccccn1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 1/20 0.33
NPC1 O15118 5/20 0.32
RAB9A P51151 4/20 0.32
SMN1; SMN2 Q16637 4/20 0.32
KDM4E B2RXH2 4/20 0.32
PKM P14618 3/20 0.32
HSD17B10 Q99714 3/20 0.32
HPGD P15428 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
TP53 P04637 2/20 0.32
ALDH1A1 P00352 2/20 0.32
MITF O75030 1/20 0.32
GAA P10253 1/20 0.32
TSHR P16473 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PGR P06401 1/20 0.30
CYP1A1 P04798 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP1B1 Q16678 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17759143 0.97 KCNA3 (0.34) KCNA3NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL17759214 0.91 CCR1 (0.32) NPC1SMN1; SMN2KDM4E
SCHEMBL17759048 0.90 NPC1 (0.35) KCNA3NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL17759067 0.89
SCHEMBL17759005 0.89 CYP3A4 (0.32)
SCHEMBL17759004 0.87 CCR1 (0.33) NPC1SMN1; SMN2KDM4E
SCHEMBL17758988 0.87
SCHEMBL17759137 0.87 NPC1 (0.35) KCNA3NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL17759008 0.85 CYP3A4 (0.32)
SCHEMBL17759065 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160141522-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2016-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160141522-A1 Organic Electroluminescent Materials and Devices EED, ICOSLG, OCIAD1 KCNA3 236/4885NPC1 4554/4885RAB9A 2936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.